Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. GOOG
6. IBM
7. CSX
8. LVS
9. KNX
10. INTC

Go back to Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine
StemCells, Inc. (NASDAQ: TEM) Delayed: 46.96 --0 (-0%)
Previous Close $46.96    52 Week High $0.45 
Open $46.96    52 Week Low $0.37 
Day High $46.96    P/E N/A 
Day Low $46.96    EPS $-0.31 
Volume 187,770